SCHEMBL8313103

SCHEMBL8313103

CN1CCC(N(C)Cc2ccc(OCCCN3CCC(Cc4c[nH]cn4)CC3)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 7/20 0.51
HRH3 Q9Y5N1 3/20 0.44
TMEM97 Q5BJF2 1/20 0.44
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3569353 0.80 HRH3 (0.69) HRH3
SCHEMBL16843151 0.79 CYP2D6 (0.69) CYP2D6HRH3
SCHEMBL17285888 0.76 HTR2A (0.60) CYP2D6HRH3
SCHEMBL8320205 0.74 HTR2A (0.54) HRH3
Methimepip SCHEMBL8320104 0.73 HRH3 (0.51) HRH3
SCHEMBL3577327 0.71 HRH3 (0.69) HRH3
SCHEMBL22878461 0.67 HTR2A (0.48) CYP2D6HRH3
SCHEMBL17284448 0.66 HTR2A (0.47) CYP2D6HRH3
SCHEMBL17286035 0.66 HTR2A (0.56)
SCHEMBL17285945 0.66 LTA4H (0.56) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9688989-B2 H4 receptor inhibitors for treating tinnitus SENSORION (FR) 2017-06-27 US disclosed
US-20150176010-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2015-06-25 US disclosed
WO-2004066960-A2 COMBINATION OF H1, H3 AND H4 RECEPTOR ANTAGONISTS FOR TREATMENT OF ALLERGIC AND NON-ALLERGIC PULMONARY INFLAMMATION, CONGESTION AND ALLERGIC RHINITIS SCHERING CORPORATION (US) 2004-08-12 WO disclosed